Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04841148 |
| Title | Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY) |
| Acronym | PALAVY |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Abramson Cancer Center of the University of Pennsylvania |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Georgetown University | RECRUITING | Washington | District of Columbia | 20007 | United States | Details |
| University of Chicago | RECRUITING | Chicago | Illinois | 60637 | United States | Details |
| Indiana University | RECRUITING | Indianapolis | Indiana | 46202 | United States | Details |
| Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| University of Pennsylvania | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |
| Vanderbilt University | RECRUITING | Nashville | Tennessee | 37232 | United States | Details |
| University of Washington | RECRUITING | Seattle | Washington | 98195 | United States | Details |